Abstract
The c-Jun N-terminal kinase (JNKs), also known as stress-activated protein kinase (SAPK), is one such family of multifunctional-signaling molecules, activated in response to wide range of cellular stresses as well as in response to inflammatory mediators. JNKs regulate various processes such as brain development, repair, and memory formation; but on the other hand, JNKs are potent effectors of neuroinflammation and neuronal death. A large body of evidence indicates that JNK activity is critical for normal immune and inflammatory response. Indeed, aberrant activation of JNK has been implicated in the pathogenesis of Alzheimer’s disease. Moreover, the JNK pathway is considered to be a key regulator of various inflammatory pathways which are activated during normal aging and Alzheimer’s disease therapy as well as key regulator of pro-inflammatory cytokines biosynthesis at the transcriptional and translational levels, which makes different components of these pathway potential targets for the treatment of autoimmune and inflammatory diseases. Pharmacological inhibition of JNK has been demonstrated to attenuate microglial activation and the release of neurotoxic chemicals including pro-inflammatory cytokines. In this review, we provide an overview on implications and therapeutic strategies of JNK in neurodegenerative disorders.
Similar content being viewed by others
References
Alarcon-Vargas D, Ronai Z (2004) C-Jun-NH2 kinase (JNK) contributes to the regulation of c-My protein stability. J Biol Chem 279:5008–5016
Barry CE, Nolan Y, Clarke RM, Lynch A, Lynch MA (2005) Activation of c-Jun-terminal kinase is critical in mediating lipopolysachharide-induced changes in the rat hippocampus. J Neurochem 93:221–231
Becker EB, Bonni A (2006) Pinl mrdiates neural-specific activation of the mitochondrial apoptotic machinery. Neuron 49:655–662
Behrens A, Sibilia M, Wagner EF (1999) Amino-terminal phosphorylation of c-Jun regulates stress-induced apoptosis and cellular proliferation. Nat Genet 21:326–329
Bendotti C, Tortarolo M, Borsello T (2006) Targeting stress activated protein kinases, JNK and p38, as new therapeutic apporoach for neurodegenerative diseases. Cent Nerv Syst Agents Med Chem 6:1–9
Ben-Zvi A, Yagil Z, Hagalili Y, Klein H, Lerman O, Behre O (2006) Semaphorin 3A and neurotrophins: a balance between apoptosis and survival signalling in embryonic DRG neurons. J Neurochem 96:585–597
Bevilaqua LR, Kerr DS, Medina JH, Izquierdo I, Cammarota M (2003) Inhibition of hippocampal jun N-terminal kinase enhances short-term memory but blocks long-term memory formation and retrieval of an inhibitory avoidance task. Eur J Neurosci 17:897–902
Bjorkblom B, Ostman N, Hongisto V, Komarovski V, Filen JJ, Nyman TA, Kallunki T, Courtney MJ, Coffey ET (2005) Constitutively active cytoplasmic c-Jun-N-terminal kinase 1 is a dominant regulator of dendritic architecture: role of microtubule-associated protein 2 as an effector. J Neurosci 25:6350–6361
Blass JP, Gibson GE, Sheu RK (2000) Inherent abnormalities in energy metabolism in Alzheimer disease. Interaction with cerebrovascular compromise. Ann NY Acad Sci 903:204–221
Bogoyevitch MA, Kobe B (2006) Uses for JNK: the many and varied substrates of the c-Jun-N-terminal kinases. Microbiol Mol Biol Rev 70:1061–1095
Brecht S, Kirchhof R, Chromik A, Willesen M, Nicolaus T, Raivich G, Wessig J, Waetzig V, Goetz M, Claussen M, Pearse D, Kuan CY, Vaudano E, Behrens A, Wagner E, Flavell RA, Davis RJ, Herdegen T (2005) Specific pathophysiological functions of JNK isoforms in the brain. Eur J Neurosci 21:363–377
Brust TB, Cayabyab FS, Mac Vicar BA (2007) C-Jun-N-terminal kinase regulates A1 receptor-mediated synaptic depression in the rat hippocampus. Neuropharmacol 53:906–917
Buee L, Bussiere T, Buee-Scherrer V, Delacourte A, Hof PR (2000) Tau protein isoforms, phospho-rylation and role in neurodegenerative disorders. Brain Res Rev 33:95–130
Carboni S, Hiver A, Szyndralewiez C, Gaillard P, Gotteland JP, Vitte PA (2004) AS601245 (1, 3-benzothiazol-2-yl (2-[[2-(3-pyridinyl) ethyl] amino[4 pyrimidinyl) acetonitrile): a c-Jun NH2-terminal protein kinase inhibitor with neuroprotective properties. J Pharmacol Exp Ther 310:25–32
Carboni S, Boschert U, Gaillard P, Gotteland JP, Gillon JY, Vitte PA (2008) AS601245, a c-Jun NH2-terminal kinase (JNK) inhibitor, reduces axon/dendrite damage and cognitive deficits after global cerebral ischaemia in gerbils. Br J Pharmacol 153:157–163
Chang L, Jones Y, Ellisman MH, Goldstein LS, Karin M (2003) JNK1 is required for maintenance of neuronal microtubules and controls phosphorylation of microtubule-associated proteins. Dev Cell 4:521–533
Chen Z, Cobb MH (2006) Activation of MEKK1 by Rho GTPases. Method in Enzymology 406:468–478
Chong ZZ, Li F, Maiese K (2005) Stress in the brain: novel cellular mechanisms of injury linked to Alzheimer’s disease. Brain Res Rev 49:1–21
Ciani L, Salinas PC (2007) c-Jun N-terminal kinase (JNK) cooperates with Gsk3-beta to regulate disheveled-mediated microtubule stability. BMC Cell Biol 8:27
Coffey ET, Hongisto V, Dickens M, Davis RJ, Courtney MJ (2000) Dual roles for c-Jun-N-terminal kinase in developmental and stress responses in cerebellar granule neurons. J Neurosci 20:7602–7613
Coffey ET, Smiciene G, Hongisto V, Cao J, Brecht S, Herdegen T, Courtney MJ (2002) C-Jun-N-terminal protein kinase (JNK2/3) is specifically activated by stress, mediating c-Jun activation, in the presence of constitutive JNK1 activity in cerebral neurons. J Neurosci 22:4335–4345
Cole GM, Frautschy SA (2007) The role of insulin and neurotrophic factor signaling in brain aging and Alzheimer’s disease. Exp Gerontol 42:10–21
Cole-Edwards KK, Musto AE, Bazan NG (2006) c-Jun N-terminal kinase activation responses induced by hippocampal kindling are mediated by reactive astrocytes. J Neurosci 26:8295–8304
Colombo A, Repici M, Pesaresi M, Santambrogio S, Forloni G, Borsello T (2007) The TAT-JNK inhibitor peptide interferes with beta amyloid protein stability. Cell Death Differ 14:1845–1848
Costello DA, Herron CE (2004) The role of c-Jun N-terminal kinase in the A beta-mediated impair-ment of LTP and regulation of synaptic transmission in the hippocampus. Neuropharmacology 46:655–662
Curran BP, Murray HJ, O’Connor JJ (2003) A role for c-Jun N-terminal kinase in the inhibition of long-term potentiation by interleukin-1beta and long-term depression in the rat dentate gyrus in vitro. Neuroscience 118:347–357
Dajas-Bailador F, Jones EV, Whitmarsh AJ (2008) The JIP1 scaffold protein regulates axonal develop-ment in cortical neurons. Curr Biol 18:221–226
Daniels RH, Hall PS, Bokoch GM (1998) Membrane targeting of p21-activated kinase1 (PAK1) induces neurite outgrowth from PC12 cells. EMBO J 17:754–764
Davis RJ (1999) Signal transduction by the C-jun-N-terminal kinase. Biochem Soc Symp 64:1–12
Davis RJ (2000) Signal transduction by the JNK group of MAP kinases. Cell 103:239–252
Derijard B, Hibi M, Wu IH, Barrett T, Su B, Deng T, Karin M, Davis RJ (1994) JNK1: a protein kinase stimulated by uv light and Ha-Ras that binds and phosphorylates the c-jun activation domain. Cell 76:1025–1037
Deshmukh R, Sharma V, Mehan S, Sharma N, Bedi KL (2009) Amelioration of intracerebroventricular streptozotocin induced cognitive dysfunction and oxidative stress by vinpocetine—a PDE1 inhibitor. Eur J Pharmacol 620:49–56
Dias-Santagata D, Fulga TA, Duttaroy A, Feany MB (2007) Oxidative stress mediates tau-induced neurodegeneration in Drosophila. J Clin Invest 117:236–245
Dickens M, Rogers JS, Cavanagh J, Raitano A, Xia Z, Halpern JR, Greenberg ME, Sawyers CL, Davis RJ (1997) A cytoplasmic inhibitor of the JNK signal transduction pathway. Science 277:693–696
Donovan N, Becker EB, Konishi Y, Bonni A (2002) JNK phosphorylation and activation of BAD couples the stress-activated signaling pathway to the cell death machinery. J Biol Chem 277:40944–40949
Eminel S, Roemer L, Waetzig V, Herdegen T (2008) C-Jun-N-terminal kinases trigger both degeneration and neurite outgrowth in primary hippocampal and cortical neurons. J Neurochem 104:957–969
Esneault E, Castagne V, Moser P, Bonny C, Bernaudin M (2008) D-JNKi, a peptide inhibitor of c-Jun N-terminal kinase, promotes functional recovery after transient focal cerebral ischemia in rats. Neuroscience 152:308–320
Figueiredo C, Pais TF, Gomes JR, Chatterjee S (2008) Neuron-microglia crosstalk up-regulates neuronal FGF-2 expression which mediates neuroprotection against excitotoxicity via JNK1/2. J Neurochem 107:73–85
Force T, Kuida K, Namchuk M, Parang K, Kyriakis JM (2004) Inhibitors of protein kinase signaling pathways. Circulation 109:1196–1205
Gallagher ED, Gutowski S, Sternweis PC, Cobb MH (2004) RhoA binds to the amino terminus of MEKK1 and regulates its kinase activity. J Biol Chem 279:1872–1877
Gallo KA, Johnson GL (2002) Mixed-lineage kinase control of JNK and p38 MAPK pathway. Cell Molecular Nature Reviews 3:663–672
Gao Y, Signore AP, Yin W, Cao G, Yin XM, Sun F, Luo Y, Graham SH, Chen J (2005) Neuroprotection against focal ischemia brain injury by inhibition of C-Jun-N-terminal kinase and attenuation of the mitochondrial apoptosis-signaling pathway. J Metab 25:694–712
Gdalyahu A, Ghosh I, Levy T, Sapir T, Sapoznik S, Fishler Y, Azoulai D, Reiner O (2004) DCX, a new mediator of the JNK pathway. EMBO J 23:823–832
Gibson GE, Blass JP (1976) Impaired synthesis of acetylcholine in brain accompanying mild hypoxia and hypoglycaemia. J Neurochem 27:37–42
Gibson GE, Sheu KF, Blass JP (1998) Abnormalities of mitochondrial enzymes in Alzheimer Disease. J Neural Transm 105:855–870
Grunblatt E, Petrisic MS, Osmanovic J, Riederer P, Hoyer S (2007) Brain insulin system dysfunction in streptozotocin intracerebroventricularly treated rats generates hyperphosphorylated tau protein. J Neurochem 101:757–770
Guan QH, Pie DS, Zhang QG, Hao ZB, Xu TL, Zhang GY (2005) The neuroprotective action of SP600125, a new inhibitor of JNK, on transient brain ischemia/reperfusion-induced neuronal death in rat hippocampal CA1 via nuclear and non-neuclear pathways. Brain Res 1035:51–59
Guo C, Whtimarsh AJ (2008) The beta-arrestin-2 scaffold protein promotes c-jun-N-terminal kinase-3 activation by binding to its nonconserved N terminus. J Biol Chem 283:15903–15911
Gupta S, Barrett T, Whitmarsh AJ, Cavanagh J, Sluss HK, Derijard B, Davis RJ (1996) Selective interaction of JNK protein kinase isoforms with transcription factors. EMBO J 15:2760–2770
Ha HY, Cho IH, Lee KW, Song JY, Kim KS, Yu YM, Lee JK (2005) The axon guidance defect of the telencephalic commissures of the JSAP1-deficient brain was partially rescued by the transgenic expression of JIP1. Dev Biol 277:184–199
Haeusgen W, Boehm R, Zhao Y, Herdegen T, Waetzig V (2009) Specific activities of individual C-Jun N-terminal kinase in the brain. Neurosci 161:951–959
Harding TC, Xue L, Bienemann A, Haywood D, Dickens M, Tolkovsky AM, Uney JB (2001) Inhibition of JNK by overexpression of the JNL binding domain of JIP-1 prevents apoptosis in sympathetic neurons. J Biol Chem 276:4531–4534
Harris CA, Johnson EM Jr (2001) BH3-only Bcl-2 family members are coordinately regulated by the JNK pathway and require Bax to induce apoptosis in neurons. J Biol Chem 276:377754–377760
Hashimoto Y, Tsuji O, Niikura T, Yamagishi Y, Ishizaka M, Kawasumi M, Chiba T, Kanekura K, Yamada M, Tsukamoto E, Kouyama K, Terashita K, Aiso S, Lin A, Nishimoto I (2003) Involvement of c-Jun N-Terminal kinase in amyloid precursor protein-meiated neuronal cell death. J Neurochem 84:864–877
Heo YS, Kim SK, Seo CI, Kim YK, Sung BJ, Lee JI, Park SY, Kim JH, Hwang KY, Hyun YL, Jeon YH, Ro S, Cho JM, Lee TG, Yang CH (2004) Structural basis for the selective inhibition of JNK1 by the scaffolding protein JIP1 and SP600125. EMBO J 23:2185–2195
Herdegen T, Leah JD (1998) Inducible and constitutive transcription factors in the mammalian nervous system: control of gene expression by Jun, Fos and Krox and CREB/ATF proteins. Brain Res Brain Res Rev 28:370–390
Herdegen T, Waetzig V (2001) The JNK and p38 signal transduction following axotomy, restor. Neurol Neurosci 19:29–39
Hidding U, Mielke K, Waetzig V, Brecht S, Hanisch U, Behrens A, Wagner E, Herdegen T (2002) The c-Jun N-terminal kinases in cerebral microglia: immunological functions in the brain. Biochem Pharmacol 64:781–788
Hirari S, Cuide F, Miyata T, Ogawa M, Kiyonari H, Suda Y, Aizawa S, Banba Y, Ohno S (2006) The c-Jun N-terminal kinase activator dual leucine zipper kinase regulates axon growth and neuronal migration in the developing cerebral cortex. J Neurosci 26:11992–12002
Hui L, Pei DS, Zhang QG, Guan QH, Zhang GY (2005) The neuroprotection of insulin on ischemic brain injury in rat hippocampus through negative regulation of JNK signaling pathway by PI3K/AKT activation. Brain Res 1052:1–9
Hunot S, Vila M, Teismann P, Davis RJ, Hirsch EC, Przedborski S, Rakic P, Flavell RA (2004) JNK-mediated induction of cyclooxygenase 2 is required for neurodegeneration in a mouse model of Parkinson’s disease. Proc Natl Acad Sci USA 101:665–670
Jang S, Kelley KW, Johnson RW (2008) Luteolin reduces IL-6 production in microglia by inhibiting JNK phosphorylation and activation of AP-1. Proc Natl Acad Sci USA 105:7534–7539
Jellinger KA (2006) Alzheimer 100-highlights in the history of Alzheimer research. J Neural Transm 113:1603–1623
Johnson GL, Nakamura K (2007) The c-Jun kinase/stress activated pathway: regulation, function and role in human disease. Biochem Biophys Acta 1773:1341–1348
Kallunki T, Su B, Tsigelny I, Sluss H, Derijard B, Moore G, Dasvis R, Karin M (1994) JNK 2 contains a specificity-determined region responsible for efficient c-Jun binding and phosphorylation. Genes Dev 8:2996–3007
Kaneto H, Matsuoka TA, Nakatani Y, Kawamori D, Matsuhisa M, Yamasaki Y (2005) Oxidative stress and the JNK pathway in diabetes. Curr Diab Rev 1:65–72
Katsuno M, Morishima-Kawashima M, Saito Y, Yamanouchi H, Ishiura S, Murayama S, Ihara Y (2005) Independent accumulations of tau and amyloid beta-protein in the human entorhinal cortex. Neurolo 64:687–692
Kawauchi T, Chihama K, Nabeshima Y, Hoshino M (2003) The in vivo roles of STEF/Tiam1, Rac1 and JNK in cortical neuronal migration. EMBO J 22:4190–5001
Kidd PM (2005) Neurodegeneration from mitochondrial insufficiency: nutrients, stem cells, growth factors and prospects for brain rebuilding using integrative management. Altern Med Rev 10:268–293
Kita Y, Kimura KD, Kobayashi M, Ihara S, Kaibuchi K, Kuroda S, Ui M, Iba H, Konishi H, Kikkawa U, Nagata S, Fukui Y (1998) Microinjection of activated phosphatidylinositol-3 kinase induces process outgrowth in rat PC12 cells through the Rac-JNK signal transduction pathway. J Cell Sci 11:907–1115
Kuan CY, Yang DD, Samanta-Roy DR, Davis RJ, Rakic P, Flavell RA (1999) The JNK1 and JNK2 protein kinas are required for regional specific apoptosis during early brain development. Neuron 22:667–676
Kyriakis JM, Avruch J (1996) Protein kinase cascades activated by stress and inflammatiory cytokines. Bioessays 18:567–577
Kyriakis JM, Banerjee P, Nikolakaki E, Dai T, Rubie EA, Ahmad MF, Avruch MF, Woodgett JR (1994) The stress-activated protein kinase subfamily of c-Jun kinases. Nature 369:156–160
Lagalwar S, Angela L, Bongaarts G, Berry WR, Binder LI (2006) Formation of phospho-SAPK/JNK granules in the hippocampus is an early event in Alzheimer’s disease. J Neuropathol Exp Neurol 65:455–464
Lee DY, Oh YJ, Jin BK (2005) Thrombin-activated microglia contribute to death of dopaminergic neurons in rat mesencephalic cultures: dual roles of mitogen-activated protein kinase signaling pathways. Glia 51:98–110
Levkovitz Y, Ben-Shushan G, Hershkovitz A, Isaac R, Gil-Ad I, Shvartman D, Ronen D, Weizman A, Zick Y (2007) Antidepressant induces cellular insulin resistance by activation of IRS-1 kinases. Mol Cell Neurosci 37:305–312
Li XM, Li CC, Yu SS, Chen JT, Sabapathy K, Ruan DY (2007) JNK1 contributes to metabotropic glutamate receptor-dependent long-term depression and short-term synaptic plasticity in the mice area hippocampal CA1. Eur J Pharmacol 25:391–396
Liao YF, Wang BJ, Cheng HT, Kuo LH, Wolfe MS (2004) Tumour necrosis factor-a, interleukin-1b, and interferone-g stimulate g-secretase mediated cleavage of Amyloid Precursor Protein through a JNK-dependent MAPK pathway. J Biol Chem 279:49523–49532
Lindwall C, Kanje M (2005) The Janus role of c-Jun: cell death versus survival and regeneration of neonatal sympathetic and sensory neurons. Exp Neurol 196:184–194
Lindwall C, Dahlin L, Lundborg G, Kanje M (2004) Inhibition of c-Jun phosphorylation reduces axonal outgrowth of adult rat nodose ganglia and dorsal root ganglia sensory neurons. Mol Cell Neurosci 27:267–279
Liu F, Liang Z, Gong CX (2006) Hyperphosphorylation of tau and protein phosphatase in Alzheimer’s disease. Panminerva Med 48:97–108
Lotharius J, Falsig J, van Beek J, Payne S, Dringen R, Brundin P, Leist M (2005) Progressive degeneration of human mesencephalic neuron-derived cells triggered by dopamine-dependent oxidative stress is dependent on the mixed-lineage kinase pathway. J Neurosci 25:6329–6342
Maiese K, Chong ZZ (2004) Insight into oxidative stress and potential novel therapeutic target for Alzhiemer’s disease. Restor Neurol Neurosci 22:87–104
Manning AM, Davis RJ (2003) Targeting JNK for therapeutic benefit: from junk to gold. Nature Reviews 2:554–565
Mason RP, Leeds PR, Jacob RF, Hough CJ, Zhang KG, Mason PE, Chuang DM (1999) Inhibition of excessive neuronal apoptosis by the calcium antagonist amlodipine and antioxidants in cerebellar granule cells. J Neurochem 72:1448–1456
Mei Y, Yuan Z, Song B, Li D, Ma C, Hu C, Ching YP, Li M (2008) Activating transcription factor 3 up-regulated by c-Jun NH(2)-terminal kinase/c-Jun contributes to apoptosis induced by potassium deprivation in cerebellar granule neurons. Neuroscience 151:771–779
Mehan S, Miishra D, Sankhla R, Singh M (2010) Mitogen activated protein kinase at the crossroads of Alzheimer’s diseases. Inter J Pharma Prof Res 1:52–60
Moreira PI, Honda K, Liu Q, Alviev G, Oliveira CR, Santos MS, Zhu X, Smith A, Perry G (2005) Alzheimer’s disease and oxidative stress: the old problem remains unsolved. Curr MedChem–Cent Nerv Sys Agents 5:51–62
Moreira PI, Duarte AI, Santos MS, Rego AC, Oliveria CR (2009) An integrative review of the role of oxidative stress, mitochondria and insulin in Alzheimer’s disease. J Alz Dis 16:741–761
Musti AM, Taylor M, Bohmann D (1997) Reduced ubiquitin-dependent degradation of c-Jun after phosphorylation by MAP kinases. Science 275:400–402
Newbern J, Taylor A, Robinson M, Lively MO, Miligan CE (2007) c-Jun N-terminal kinase signaling regulates events associated with both health and degeneration in motoneurons. Neurosci 147:680–692
Oh HL, Seok JY, Kwon CH, Kang SK, Kim YK (2006) Role of MAPK in ceramide-induced cell death in primary cultured astrocytes from mouse embryonic brain. Neurotoxicol 27:31–38
Oliva AA, Atkins CM, Copenagle L, Banker GA (2006) Activated c-Jun N-terminal kinase is required for axon formation. J Neurosci 26:9462–9470
Parihar MS, Brewer GJ (2007) Mitoenergetic failure in Alzheimer disease. Am J Physiol Cell Physiol 292:8–23
Patel MS, Korotchkina LG (2006) Regulation of pyruvate dehydrogenase complex. Biochem Soc Trans 34:217–222
Planel E, Tatebayashi Y, Miyasaka T, Liu L, Wang L, Herman M, Yu WH, Luchsinger JA, Wadzinski B, Duff KE, Takashima A (2007) Insulin dysfunction induces in vivo tau hyperphosphorylation through distinct mechanisms. J Neurosci 27:13635–13648
Pocivavsek A, Burns MP, Rebeck GW (2009) Low-density lipoprotein receptors regulate microglial inflammation through c-Jun N-terminal kinase. Glia 57:444–453
Precept (2007) Mixed lineage kinase inhibitor CEP-1347 fails to delay disability in early Parkinson disease. Neurology 69:1480–1490
Pulverer BJ, Kyriakis JM, Avruch J, Nikolakaki E, Woodgett JR (1991) Phosphorylation of C-jun mediated by MAP kinases. Nature 353:670–674
Putcha GV, Le S, Frank S, Besirli CG, Clark K, Chu B, Alix S, Youle RJ, LaMarche A, Maroney AC, Johnson EM Jr (2003) JNK-mediated BIM phosphorylation potentiates BAX-dependent apoptosis. Neuron 38:899–914
Raivich G, Behrens A (2006) Role of the AP-1 transcription factor c-Jun in developing, adult and injured brain. Prog Neurobiol 78:347–363
Raivich G, Bohatschek M, Kloss CU, Werner A, Jones LL, Kreutzberg GW (1999) Neuroglial activation repertoire in the injured brain: graded response, molecular mechanisms and cues to physiological function. Brain Res Brain Res Rev 30:77–105
Raivich G, Bohatschek M, Da Costa C, Iwata O, Galiano M, Hristova M, Nateri AS, Makwana M, Riera-Sans L, Wolfer DP, Lipp HP, Aguzzi A, Wagner EF, Behrens A (2004) The AP-1 transcription factor c-Jun is required for efficient axonal regeneration. Neuron 43:57–67
Repici M, Mare L, Colombo A, Ploia C, Sclip C, Bonny C, Nicod P, Salmona M, Borsello T (2009) C-Jun-N-terminal kinase-bibding domain-dependent phosphorylation of mitogen-actvated protein kinase kinase 7 and balancing cross-talk between C-Jun N-terminal kinase and extracellular signal-regulated kinase pathways in cortical neurons. Neurosci 159:94–103
Riese U, Ziegler E, Hamburger M (2004) Militarinone A induces differentiation in PC12 cells via MAP and AKT Kinase signal transduction pathways. FEBS Lett 577:455–459
Rosso SB, Sussman D, Wynshaw-Boris A, Salinas PC (2005) Wnt signaling through disheveled, Rac and JNK regulates dendritic development. Nat Neurosci 8:34–42
Sabapathy K, Joohum W, Hochedlinger K, Chang L, Karin M, Wagner EF (1999) Defective neural tube morphogenesis and altered apoptosis in the absence of both JNK1 and JNK2. Mech of Devel 89:115–124
Sato S, Ito M, Ito T, Yoshioka K (2004) Scaffold protein JSAP1 is transported to growth cones of neuritis independent of JNK signaling pathways in PC12h cells. Genes 329:51–60
Sato T, Torashima T, Sugihara K, Hirai H, Asano M, Yoshioka K (2008) The scaffold protein JSAP1 regulates proliferation and differentiation of cerebellar granule cell precursors by modulating JNK signaling. Mol Cell Neurosci 39:569–578
Sharma M, Gupta YK (2002) Chronic treatment with resveratrol prevents intracerebro-ventricular streptozotocin induced cognitive impairment and oxidative stress in rats. Life Sci 71:2489–2498
Shaw D, Wang SM, Villasenor AG, Tsing S, Walter D, Browner MF, Barnett J, Kuglstatter A (2008) The crystal structure of JNK2 reveals conformational flexibility in the MAP kinase insert and indicates its involvement in the regulation of catalytic activity. J Mol Biol 383:885–893
Shen C, Chen Y, Liu H, Zhang K, Zhang T, Lin A, Jing N (2008) Hydrogen peroxide promotes Abeta production through JNK-dependent activation of gamma-secretase. J Biol Chem 283:17721–17730
Shoham S, Bejar C, Kovalev E, Weinstock M (2003) Intracerebroventricular injection of streptozotocin causes neurotoxicity to myelin that contributes to spatial memory deficits in rats. Exp Neurol 184:1043–1052
Smeal T, Binetruy B, Mercola DA, Birrer M, Karin M (1991) Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serine 63 and 73. Nature 354:494–496
Smeal T, Binetruy B, Mercola D, Grover-Bardwick A, Heidecker G, Rapp UR, Karin M (1992) Oncoprotein mediated signaling cascade stimulates c-Jun activity by phosphorylation of serine 63 and 73. Mol And Cell Biol 12:3507–3513
Smith MA, Nunomura A, Zhu X, Takeda A, Perry G (2002) Metabolic, metallic and mitotic sources of oxidative stress in Alzheimer disease. Antioxid Redox Signal 2:413–420
Soane L, Kahraman S, Kristian T, Fiskum G (2007) Mechanism of impaired mitochondrial energy metabolism in acute and chronic neurodegenerative disorders. J Neurosci Res 85:3407–3415
Sonkusare S, Srinivasan K, Kaul C, Ramarao P (2005) Effect of Donepezil and lercanidipine on memory impairment induced by intracerebroventricular streptozotocin in rats. Life Sci 77:1–14
Sorbi S, Bird ED, Blass JP (1983) Decreased pyruvate dehydrogenase complex activity in Huntington and Alzheimer brain. Ann Neurol 13:72–78
Steen E, Terry BM, Rivera EJ, Cannon JL, Neely TR, Tavares R, Xu XJ, Wands JR, de la Monte SM (2005) Impaired insulin and insulin-like growth factor expression and signaling mechanisms in lzheimer’s disease-is this type 3 diabetes? J Alz Dis 7:63–80
Suckfuell M, Canis M, Strieth S, Scherer H, Haisch A (2007) Intratympanic treatment of acute acoustic trauma with a cell-permeable JNK ligand: a prospective randomized phase I/II study. Acta Otolaryngol 127:938–942
Sugino T, Nozaki K, Takagi Y, Hattori I, Hashimoto N, Moriguchi T, Nishida E (2000) Activation of mitogen-activated protein kinases after transient forebrain ischemia in gerbil hippocampus. J Neurosci 20:4506–4514
Suto R, Tominaga K, Mizuguchi H, Sasaki E, Higuchi K, Kim S, Iwao H, Arakawa T (2004) Dominant-negative mutant of c-jun gene transfer: a novel therapeutic strategy for colorectal cancer. Gene Ther 11:187–193
Takatori A, Geth E, Chen L, Zhang L, Meller J, Xia Y (2008) Differential transmission of MEKK1 morphogenetic signals by JNK1 and JNK2. Development 135:23–32
Tang SC, Lathia JD, Selvaraj PK, Jo DG, Mughal MR, Cheng A, Siler DA, Markesbery WR, Arumugam TV, Mattson MP (2008) Toll-like receptor-4 mediates neuronal apoptosis induced by amyloid betapeptide and the membrane lipid peroxidation product 4-hydroxynonenal. Exp Neurol 213:114–121
Tararuk T, Ostman N, Li W, Bjorkblom B, Padzik A, Zdrojewska J, Hongisto V, Herdegen T, Konopka W, Courtney MJ, Coffey ET (2006) JNK1 phosphorylation of SCG10 determines microtubule dynamics and axodendritic length. J Cell Biol 173:265–277
Thomas GM, Lin DT, Nuriya M, Huganir RL (2008) Rapid and bidirectional regulation of AMPA receptor phosphorylation and trafficking by JNK. EMBO J 27:361–372
Tournier C, Hess P, Yang DD, Xu J, Turner TK, Nimnual A, Bar-Sagi D, Jones SN, Flavell RA, Davis RJ (2000) Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Sience 288:870–874
Tretter L, Adam-Vizi V (2000) Inhibition of Krebs cycle by hydrogen peroxide: a key role of a-ketoglutarate dehydrogenase in limiting NADH production under oxidative stress. J Neurosci 20:8972–8979
Varona-Santos JL, Pileggi A, Molano RD, Sanabria NY, Ijaz A, Atsushi M, Ichii H, Pastori RL, Inverardi L, Ricordi C, Fornoni A (2008) C-J-un-N-terminal kinase 1 is deleterious to the function and survival of murine islets. Diabetologia 51:2271–2280
Waetzig V, Herdegen T (2003) The concerted signaling of ERK1/2 and JNKs is essential for PC12 cell neuritogenesis and converges at the level of target proteins. Mol Cell Neurosci 24:238–249
Waetzig V, Zhao Y, Herdegen T (2006) The bright side of JNKs: multitalented mediators in neuronal sprouting, brain development and nerve fiber regeneration. Prog Neurobiol 80:84–97
Waetzig V, Herdegen T (2004) Neurodegenerative and physiological actions of c-Jun N-terminal kinases in the mammalian brain. Neurosci Letters 361:64–67
Waetzig V, Czeloth K, Hidding U, Mielke K, Kanzow M, Brecht S, Goetz M, Lucius R, Herdegen T, Hanisch UK (2005) C-Jun N-terminal kinases (JNKs) mediate pro-inflammatory actions of microglia. Glia 50:235–346
Wang MJ, Jeng KCG, Kuo JS, Chen HL, Huang HY, Chen WF, Lin SZ (2004) C-Jun-N-terminal kinase and, to lesser extent, p38 mitogen-activated protein kinase regulate inducible nitric oxide synthase expression in hyaluronan fragments-stimulated BV-2 microglia. J Neuroimmunol 146:50–62
Wang X, Nadarajah B, Robinson AC, McColl BW, Jin JW, Dajas-Bailador F, Boot-Handford RP, Tournier C (2007a) Targeted deletion of the mitogen-activated protein kinase kinase 4 gene in the nervous system causes severe brain developmental defects and premature death. Mol Cell Biol 27:7935–7946
Wang X, Destrument A, Tournier C (2007b) Physiological roles of MKK4 and MKK7: insight from animal models. Biochem Biophys Acta 1773:1349–1357
Weston CR, Davis RJ (2007) The JNK signal transduction pathway. Curr Opin Cell Biol 19:142–149
Whitmarsh AJ (2006) The JIP family of MAPK scaffold proteins. Biochem Sco Trans 34:828–832
Widmann C, Gibson S, Jarpe MB, Johnson GL (1999) Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol Rev 79:143–180
Wu J, Zhang X, Nauta HJ, Lin Q, Li J, Fang L (2008) JNK1 regulates histone acetylation in trigeminal neurons following chemical stimulation. Biochem Biophys Res Commun 376:781–786
Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME (1995) Opposing effects of ERK and JNK-p38 MAPK kinase on apoptosis. Science 24:1326–1331
Xie X, Gu Y, Fox T, Coll JT, Fleming MA, Markland W, Caron PR, Wilson KP, Su MS (1998) Crystal structure of JNK3: a kinase implicated in neuronal apoptosis. Structure 6:983–991
Yamauchi J, Miyamoto Y, Murabe M, Fujiwara Y, Sanbe A, Fujita Y, Murase S, Tanoue A (2007) Gadd45a, the gene induced by the mood stabilizer valproic acid, regulates neurite outgrowth through JNK and the substrate paxillin in N1E-115 neuroblastoma cells. Exp Cell Res 313:1886–1896
Yang DD, Kuan CY, Whitmarsh AJ, Rincon M, Zheng TS, Davis RJ, Rakic P, Flavell RA (1997) Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene. Nature 389:865–70
Yang JY, Moulin N, Van Bemmelen MX, Dubuis G, Tawadros T, Haefliger JA, Waeber G, Widmann C (2007a) Splice variant-specific stabilization of JNKs by IB1/JIP1. Cell Signal 19:2201–2207
Yang Y, Zhu X, Chen Y, Wang X, Chen R (2007b) p38 and JNK MAPK, but not ERK1/2 MAPK, play important role in colchicines-induced cortical neurons apoptosis. Eur J Pharmacol 576:26–33
Yao M, Nguyen TV, Pike CJ (2005) Beta-amyloid-induced neuronal apoptosis involves c-Jun N-terminal kinase-dependent downregulation of Bcl-w. J Neurosci 25:1149–1158
Yatsushige H, Yamaguchi-Okada M, Zhou C, Calvert JW, Cahill J, Colohan ART, Zhang JH (2008) Inhibition of C-Jun-N-terminal kinase pathway attenuates cerebral vasospasm after experimental subarachnoid hemorrhage through the suppression of apoptosis. Acta Neurochir Suppl 104:27–31
Yoshida H, Hastie CJ, Mclauchlan H, Cohen P, Goedert M (2004) Phosphorylation of micro- tubule associated protein tau by isoforms of c-Jun-N-teminal kinase (JNK). J Neurochem 90:352–358
Zhang QX, Pei DS, Guan QH, Sun YF, Liu XM, Zhang GY (2007) Crosstalk between PSD-95 and JIP1-mediated signaling modules: the mechanism of MLK3 activation in cerebral ischemia. Biochemistry 46:4006–4016
Zhao WQ, Townsend M (2009) Insulin resistance and amyloidogenesis as common molecular foundation for type 2 diabetes and Alzheimer’s disease. Biochim Biophys Acta 1792:482–496
Zhou Q, Lam PY, Han D, Cadenas E (2008) C-Jun-N-terminal kinase regulates mitochondrial bioenergetics by modulating pyruvate dehydrogenase activity in primary cortical neurons. J Neurochem 104:325–335
Zhou Q, Lam PY, Han D, Cadenas E (2009) Activation of c-Jun-N-terminal kinase and decline of mitochondrial pyruvate dehydrogenase activity during brain aging. FEBS Lett 583:1132–1140
Zhu X, Castellani RJ, Takeda A, Nunomura A, Atwood CS, Perry G, Smith MA (2001a) Differential activation of neuronal ERK, JNK/SAPK and p38 in Alzheimer disease: the two hit hypothesis. Mech Ageing Dev 123:39–46
Zhu X, Raina AK, Rottkamp CA, Aliev G, Perry G, Boux H, Smith MA (2001b) Activation and redistribution of c-jun N-terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer’s disease. J Neurochem 76:435–441
Zhu Y, Pak D, Qin Y, McCormack SG, Kim MJ, Baumgart JP, Velamoor V, Auberson YP, Osten P, van Aelst L, Sheng M, Zhu JJ (2005) Rap2-JNK removes synaptic AMPA receptors during depotentiation. Neuron 46:905–16
Acknowledgement
Authors are thankful to Mr. S.N.Kachhwaha, the Chairman, G.D.Memorial College of Pharmacy, Jodhpur (Rajasthan) and Mr. Manish Kachhwaha, Director, G.D.Memorial College of Pharmacy, Jodhpur (Rajasthan) for invaluable support and encouragement. Authors also express their thankfulness to his late guide Prof. Manjeet Singh, Director Academics, ISF College of Pharmacy, Moga (Punjab) for always being with us.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mehan, S., Meena, H., Sharma, D. et al. JNK: A Stress-Activated Protein Kinase Therapeutic Strategies and Involvement in Alzheimer’s and Various Neurodegenerative Abnormalities. J Mol Neurosci 43, 376–390 (2011). https://doi.org/10.1007/s12031-010-9454-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12031-010-9454-6